e-learning
resources
Vienna 2003
Sunday 28.09.2003
New aspects of community acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
J. Blanquer, M. L. Briones, C. Muñoz, C. Gimeno, D. Blanquer, J. Marin (Valencia, Palma de Mallorca, Spain)
Source:
Annual Congress 2003 - New aspects of community acquired pneumonia
Session:
New aspects of community acquired pneumonia
Session type:
Oral Presentation
Number:
139
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Blanquer, M. L. Briones, C. Muñoz, C. Gimeno, D. Blanquer, J. Marin (Valencia, Palma de Mallorca, Spain). Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia. Eur Respir J 2003; 22: Suppl. 45, 139
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003
Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Usefullness of CPR and PCT in the etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012
Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006
Sputum and streptococcus pneumoniae urinary antigen test for diagnosis of pneumococcal community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
The comparison of different methods of etiologic diagnosis of community-acquired pneumonia
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
The pathophysiology of pneumococcal pneumonia
Source: Eur Respir Monogr 2014; 63: 42-63
Year: 2014
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression
Source: Eur Respir J 2012; 40: 1201-1210
Year: 2012
Absence of leukocytosis in bacteremic pneumococcal pneumonia
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept